Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jan 12, 2026

Discover large cap Swiss Pharmaceuticals & Biotech companies that are on the SMI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ROG Roche Holding	CHF 342.50	5.2%	29.3%	CHF 292.4b	CHF 331.47	PE30.9x	E12.8%	2.8%
NOVN Novartis	CHF 113.84	4.9%	25.4%	CHF 218.4b	CHF 109.99	PE19x	E7.5%	2.7%
LONN Lonza Group	CHF 565.80	5.6%	3.9%	CHF 39.7b	CHF 678.09	PE54.2x	E18.6%	0.7%
GALD Galderma Group	CHF 163.90	2.4%	53.2%	CHF 38.9b	CHF 166.08	PE129.1x	E27.0%	0.08%
SDZ Sandoz Group	CHF 59.90	4.7%	55.0%	CHF 25.8b	CHF 55.06	PE142.6x	E25.7%	0.9%
DESN Dottikon ES Holding	CHF 358.00	0.6%	70.9%	CHF 4.9b	CHF 460.00	PE40.9x	n/a	0%
BANB Bachem Holding	CHF 63.90	9.3%	14.5%	CHF 4.8b	CHF 73.39	PE35.7x	E15.5%	1.3%
SFZN Siegfried Holding	CHF 82.30	10.2%	-15.9%	CHF 3.6b	CHF 108.67	PE23.4x	E10.6%	0.5%
TECN Tecan Group	CHF 160.30	20.9%	-27.9%	CHF 2.0b	CHF 193.79	PE32.2x	E13.0%	1.9%
COPN Cosmo Pharmaceuticals	CHF 108.20	2.7%	71.2%	CHF 1.7b	CHF 98.04	PE30.9x	E35.2%	1.8%
SKAN SKAN Group	CHF 55.10	5.6%	-27.2%	CHF 1.2b	CHF 70.33	PE76.6x	E32.8%	0.7%
KURN Kuros Biosciences	CHF 26.00	-2.5%	12.6%	CHF 1.0b	CHF 32.80	PS9.9x	E60.9%	n/a
PPGN PolyPeptide Group	CHF 30.10	25.4%	13.2%	CHF 993.0m	CHF 34.36	PS2.9x	E65.3%	0%
IDIA Idorsia	CHF 3.70	-9.0%	411.8%	CHF 922.9m	CHF 5.00	PS4x	E26.8%	n/a
BSLN Basilea Pharmaceutica	CHF 55.40	1.7%	34.5%	CHF 680.8m	CHF 90.78	PE9.4x	E-22.6%	0%
NWRN Newron Pharmaceuticals	CHF 30.40	19.2%	229.7%	CHF 608.4m	CHF 34.93	PE25.8x	E32.7%	n/a
MMTX MindMaze Therapeutics Holding	CHF 1.53	-1.4%	n/a	CHF 233.2m	CHF 3.56	n/a	n/a	n/a
SANN Santhera Pharmaceuticals Holding	CHF 14.56	19.9%	18.2%	CHF 194.7m	CHF 30.00	PS4x	S48.7%	n/a
XLS Xlife Sciences	CHF 25.70	2.4%	-2.3%	CHF 148.2m	n/a	PE4.8x	n/a	n/a
BIOV BioVersys	CHF 22.90	-3.4%	n/a	CHF 133.9m	CHF 56.38	PS102.3x	E-14.8%	n/a
MOLN Molecular Partners	CHF 3.38	-0.3%	-30.3%	CHF 126.4m	CHF 9.00	PB1.3x	E-4.1%	n/a
CURN Curatis Holding	CHF 16.65	27.6%	15.2%	CHF 85.8m	CHF 98.10	n/a	n/a	n/a
ADXN Addex Therapeutics	CHF 0.057	7.5%	-6.9%	CHF 6.6m	n/a	PS41.9x	n/a	n/a